Dear Readers,
It is our pleasure to welcome you to the second issue of The Journal of Reproduction (TJOR). We are delighted with the positive response received for our first issue, as over 10,000 readers have engaged with the insightful articles published by researchers from diverse geographic locations.
Our hope is that this issue will continue to be well-received and inspire clinicians, biologists, psychologists, and other professionals in the reproductive health field to share their own experiences, thereby allowing colleagues from around the globe to benefit from their expertise.
We have a few announcements that we would like to share with you. Firstly, in addition to our regular quarterly issues, we will be publishing special issues focused on specific topics related to reproduction. These will cover a range of topics such as surrogate motherhood, the use of artificial intelligence (AI) in assisted reproduction, and novel approaches to treating infertility such as mitochondria transfer, spindle transfer and others. We have already reached out to top leaders in each field from different parts of the world to contribute articles. Our first special issue is planned to be published on September 1st, 2023.
Secondly, we are pleased to announce that TJOR will continue to be completely free to register, read, and publish manuscripts. To support this, we will be introducing promotional pieces from commercial companies. In this issue, our friends from Ovogene are the first to participate. We anticipate that in the future, other companies related to the field of reproduction, including pharmaceuticals, genetics laboratories, and producers of IVF laboratory instruments, will be interested in showcasing their products and work in our journal.
Lastly, we are proud to announce that TJOR is making significant progress towards achieving international certifications for inclusion in PubMed for full references approval. We have completed a lengthy process involving administrative, academic, and legal steps to obtain our certification with ISSN (International Standard Serial Number) and DOI (Digital Object Identifier) generated by Crossref. The benefits of having an ISSN include international publicity and recognition of serials by automatic inclusion in the International Serials Directory Database. An ISSN is an 8-digit code used to identify newspapers, journals, magazines,
and periodicals of all kinds, both print and electronic. A DOI is a unique string of numbers, letters, and symbols used to identify an article or document and provide it with a permanent web address (URL). Including a DOI in your citation helps readers easily locate a document. These certifications will facilitate our presence in PubMed Central and publisher websites in the near future.
We look forward to receiving your comments on our second regular issue and hope that you find the articles informative and engaging. Please accept our warmest regards.
Sincerely,
Ricardo Héctor Asch Schuff, MD.
Editor in Chief
